A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.

A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.

Item
http://www.wikidata.org/entity/Q34552465
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewA Review of Currently Available Fenofibrate and Fenofibric Acid FormulationsNanopharmaceuticals (part 1): products on the market.Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption.Bile salt/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating.Fenofibrate and metabolic syndrome.Fenofibric acid for hyperlipidemia.Recent advancements in mechanical reduction methods: particulate systems.Drug disposition before and after gastric bypass: fenofibrate and posaconazole.Comparison of the gastrointestinal absorption and bioavailability of fenofibrate and fenofibric acid in humans.In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion.The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
P2860

A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.

Item
http://www.wikidata.org/entity/Q34552465
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A new fenofibrate formulation: ...... er fed and fasting conditions.
@ast
A new fenofibrate formulation: ...... er fed and fasting conditions.
@en
A new fenofibrate formulation: ...... er fed and fasting conditions.
@nl
type
label
A new fenofibrate formulation: ...... er fed and fasting conditions.
@ast
A new fenofibrate formulation: ...... er fed and fasting conditions.
@en
A new fenofibrate formulation: ...... er fed and fasting conditions.
@nl
prefLabel
A new fenofibrate formulation: ...... er fed and fasting conditions.
@ast
A new fenofibrate formulation: ...... er fed and fasting conditions.
@en
A new fenofibrate formulation: ...... er fed and fasting conditions.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
A new fenofibrate formulation: ...... er fed and fasting conditions.
@en
P2093
P304
P31
P356
10.1016/J.CLINTHERA.2004.09.015
P433
P478
P577
P698